Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes
The advantages of real-time continuous glucose monitoring (rtCGM) over intermittently scanned CGM (isCGM) reportedly include lower glycated hemoglobin (HbA1c) levels as well as reduced glycemic variability. However, there have been few studies of the effect of switching from isCGM to rtCGM on glycem...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Japan Endocrine Society
2023-12-01
|
Series: | Endocrine Journal |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/endocrj/70/12/70_EJ23-0125/_html/-char/en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832591675913928704 |
---|---|
author | Eijiro Yamada Yasuyo Nakajima Kazuhiko Horiguchi Shuichi Okada Masanobu Yamada |
author_facet | Eijiro Yamada Yasuyo Nakajima Kazuhiko Horiguchi Shuichi Okada Masanobu Yamada |
author_sort | Eijiro Yamada |
collection | DOAJ |
description | The advantages of real-time continuous glucose monitoring (rtCGM) over intermittently scanned CGM (isCGM) reportedly include lower glycated hemoglobin (HbA1c) levels as well as reduced glycemic variability. However, there have been few studies of the effect of switching from isCGM to rtCGM on glycemic control, as well as the specific factors underlying any observed improvements. To that end, all patients with type 1 diabetes mellitus who used the DEXCOM rtCGM device (Terumo Corporation, Tokyo, Japan) at our institution were reviewed, and 16 individuals with type 1 diabetes who switched from isCGM to rtCGM were investigated. The patients’ HbA1c decreased in 75% of the cases (p = 0.02). On the other hand, GMI increased in 75% of the cases (p = 0.01). Intriguingly, the percentage of time below range and coefficient of variation were significantly improved with rtCGM compared to isCGM (2.9% vs. 7.6%, p = 0.016 and 35% vs. 40%, p = 0.0019, respectively). We also found that the discrepancy between HbA1c and GMI among users of isCGM was a key indicator that improved when switching to rtCGM. If discrepancies are observed between HbA1c and GMI when using isCGM, switching to rtCGM should be considered for improving glycemic control. |
format | Article |
id | doaj-art-0df9fd0c6cc948e79d0a1a696724528a |
institution | Kabale University |
issn | 1348-4540 |
language | English |
publishDate | 2023-12-01 |
publisher | The Japan Endocrine Society |
record_format | Article |
series | Endocrine Journal |
spelling | doaj-art-0df9fd0c6cc948e79d0a1a696724528a2025-01-22T06:25:09ZengThe Japan Endocrine SocietyEndocrine Journal1348-45402023-12-0170121187119310.1507/endocrj.EJ23-0125endocrjAssessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetesEijiro Yamada0Yasuyo Nakajima1Kazuhiko Horiguchi2Shuichi Okada3Masanobu Yamada4Department of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, Maebashi 371-8511, JapanDepartment of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, Maebashi 371-8511, JapanDepartment of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, Maebashi 371-8511, JapanDepartment of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, Maebashi 371-8511, JapanDepartment of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, Maebashi 371-8511, JapanThe advantages of real-time continuous glucose monitoring (rtCGM) over intermittently scanned CGM (isCGM) reportedly include lower glycated hemoglobin (HbA1c) levels as well as reduced glycemic variability. However, there have been few studies of the effect of switching from isCGM to rtCGM on glycemic control, as well as the specific factors underlying any observed improvements. To that end, all patients with type 1 diabetes mellitus who used the DEXCOM rtCGM device (Terumo Corporation, Tokyo, Japan) at our institution were reviewed, and 16 individuals with type 1 diabetes who switched from isCGM to rtCGM were investigated. The patients’ HbA1c decreased in 75% of the cases (p = 0.02). On the other hand, GMI increased in 75% of the cases (p = 0.01). Intriguingly, the percentage of time below range and coefficient of variation were significantly improved with rtCGM compared to isCGM (2.9% vs. 7.6%, p = 0.016 and 35% vs. 40%, p = 0.0019, respectively). We also found that the discrepancy between HbA1c and GMI among users of isCGM was a key indicator that improved when switching to rtCGM. If discrepancies are observed between HbA1c and GMI when using isCGM, switching to rtCGM should be considered for improving glycemic control.https://www.jstage.jst.go.jp/article/endocrj/70/12/70_EJ23-0125/_html/-char/entype 1 diabetesreal-time continuous glucose monitoringintermittently scanned continuous glucose monitoringglycated hemoglobin (hba1c)time below range |
spellingShingle | Eijiro Yamada Yasuyo Nakajima Kazuhiko Horiguchi Shuichi Okada Masanobu Yamada Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes Endocrine Journal type 1 diabetes real-time continuous glucose monitoring intermittently scanned continuous glucose monitoring glycated hemoglobin (hba1c) time below range |
title | Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes |
title_full | Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes |
title_fullStr | Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes |
title_full_unstemmed | Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes |
title_short | Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes |
title_sort | assessment of factors associated with improved glycemic control after switching from intermittently scanned to real time continuous glucose monitoring in japanese patients with type 1 diabetes |
topic | type 1 diabetes real-time continuous glucose monitoring intermittently scanned continuous glucose monitoring glycated hemoglobin (hba1c) time below range |
url | https://www.jstage.jst.go.jp/article/endocrj/70/12/70_EJ23-0125/_html/-char/en |
work_keys_str_mv | AT eijiroyamada assessmentoffactorsassociatedwithimprovedglycemiccontrolafterswitchingfromintermittentlyscannedtorealtimecontinuousglucosemonitoringinjapanesepatientswithtype1diabetes AT yasuyonakajima assessmentoffactorsassociatedwithimprovedglycemiccontrolafterswitchingfromintermittentlyscannedtorealtimecontinuousglucosemonitoringinjapanesepatientswithtype1diabetes AT kazuhikohoriguchi assessmentoffactorsassociatedwithimprovedglycemiccontrolafterswitchingfromintermittentlyscannedtorealtimecontinuousglucosemonitoringinjapanesepatientswithtype1diabetes AT shuichiokada assessmentoffactorsassociatedwithimprovedglycemiccontrolafterswitchingfromintermittentlyscannedtorealtimecontinuousglucosemonitoringinjapanesepatientswithtype1diabetes AT masanobuyamada assessmentoffactorsassociatedwithimprovedglycemiccontrolafterswitchingfromintermittentlyscannedtorealtimecontinuousglucosemonitoringinjapanesepatientswithtype1diabetes |